AKT1 and head and neck squamous cell carcinoma: In 2014, Freudlsperger et al. demonstrated that the inhibition of AKT (Ser473) phosphorylation might overcome radioresistance, thereby decreasing toxicity and ameliorating the efficiency of treatment in advanced HNSCC [138].